Company Filing History:
1 out of 2 
1 out of 1,744 
1 out of 205 
Years Active: 2022
Title: Monique Vallée: Innovator in Cannabinoids-Related Treatments
Introduction: Monique Vallée, an accomplished inventor based in Bordeaux, France, has made significant contributions to the field of medicinal chemistry. Her work is primarily focused on developing innovative treatments for cannabinoids-related disorders, showcasing her dedication to advancing healthcare solutions.
Latest Patents: Vallée holds a notable patent for the compound 3β-(4-methoxybenzyloxy)pregn-5-en-20-one. This invention relates specifically to a pregnenolone derivative designed for the treatment of disorders associated with cannabinoids. The unique formulation offers potential therapeutic applications that could enhance the quality of life for individuals suffering from such conditions.
Career Highlights: Throughout her career, Monique has worked with prestigious institutions, including Aelis Farma and the Institut National de la Santé et de la Recherche Médicale. Her roles at these companies have allowed her to collaborate with leading scientists and researchers in the field, contributing to her expertise and the development of groundbreaking medical treatments.
Collaborations: Vallée has worked alongside distinguished colleagues such as Pier Vincenzo Piazza and Sandy Fabre. These collaborations have been instrumental in fostering a rich exchange of ideas and research, further amplifying the impact of her patented inventions on the medical field.
Conclusion: Monique Vallée stands out as a pioneering inventor in the realm of cannabinoid-related therapeutics. Her single patent exemplifies her innovative approach to addressing complex health issues. With her background in esteemed companies and collaborations with other experts, Vallée continues to inspire future advancements in the treatment of cannabinoids-related disorders.